NORITATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Noritate, and what generic alternatives are available?
Noritate is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in NORITATE is metronidazole. There is one drug master file entry for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Noritate
A generic version of NORITATE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORITATE?
- What are the global sales for NORITATE?
- What is Average Wholesale Price for NORITATE?
Summary for NORITATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Patent Applications: | 4,124 |
| Drug Prices: | Drug price information for NORITATE |
| What excipients (inactive ingredients) are in NORITATE? | NORITATE excipients list |
| DailyMed Link: | NORITATE at DailyMed |
Pharmacology for NORITATE
| Drug Class | Nitroimidazole Antimicrobial |
US Patents and Regulatory Information for NORITATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | NORITATE | metronidazole | CREAM;TOPICAL | 020743-001 | Sep 26, 1997 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
